Integrin expression patterns of patients with IBD treated with vedolizumab.

被引：0
|
作者：
Kokkotis, G. [1 ]
Chalakatevaki, K. [1 ]
Papathanasiou, E. [2 ]
Tzanoudaki, M. [3 ]
Kane, R. [3 ]
Liatsis, M. [3 ]
Zampeli, E. [2 ]
Michopoulos, S. [2 ]
Bamias, G. [1 ]
机构：
[1] Univ Athens, Sotiria Hosp, GI Unit, Acad Dept Internal Med 3, Athens, Greece
[2] Alexandra Gen Hosp, Dept Gastroenterol, Athens, Greece
[3] Aghia Sophia Childrens Hosp, Dept Immunol & Histocompatibil, Athens, Greece
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P650
引用
收藏
页码：778 / 778
页数：1
相关论文
共 50 条
  • [1] Gene expression in intestinal transplant patients treated with vedolizumab. An exploratory analysis.
    Trentadue, Guido
    Hu, Shixian
    Jansen, Bernadien H.
    Faber, Klaas Nico
    Dijkstra, Gerard
    TRANSPLANTATION, 2023, 107 (7S) : 32 - 32
  • [2] EFFECTIVENESS AND SAFETY OUTCOMES BEYOND FIVE YEARS OF IBD PATIENTS TREATED WITH VEDOLIZUMAB. THE LONGLIVE IG-IBD STUDY
    Privitera, G.
    Pugliese, D.
    Armuzzi, A.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S114 - S114
  • [3] Effectiveness and safety outcomes beyond five years of IBD patients treated with vedolizumab. The LONG-LIVE IG-IBD study
    Privitera, G.
    Pugliese, D.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1900 - I1900
  • [4] Immunogenicity of the Influenza Vaccine in IBD Patients Treated with Vedolizumab
    Harrington, Jill E.
    Hamilton, Rachael E.
    Wasan, Sharmeel K.
    Farraye, Francis A.
    Ganley-Leal, Lisa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S407 - S408
  • [5] New onset spondyloarthropathy in vedolizumab treated IBD patients
    Tetley, A. M.
    Lobaton, T.
    Truyens, M.
    Katsanos, K. H.
    de Boer, K. H. N.
    Pattinson, A.
    Molnar, T.
    Filip, R.
    Michalopoulos, G.
    Sebastian, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S568 - S568
  • [6] OUTCOME OF PREGNANCIES IN VEDOLIZUMAB TREATED FEMALE IBD PATIENTS
    Moens, Annick
    van Hoeve, Karen
    Humblet, Evelien
    Rahier, Jean-Francois
    Bossuyt, Peter
    Dewit, Sophie
    Franchimont, Denis
    Elisabeth, Macken
    Nijs, Jochen
    Posen, Annelies
    Van Hootegem, Anneleen
    Van Moerkercke, Wouter
    Vermeire, Severine
    Ferrante, Marc
    GASTROENTEROLOGY, 2018, 154 (06) : S360 - S360
  • [7] Outcome of pregnancies in female IBD patients treated with vedolizumab
    Moens, A.
    van Hoeve, K.
    Humblet, E.
    Rahier, J-F.
    Bossuyt, P.
    Dewit, S.
    Franchimont, D.
    Macken, E.
    Nijs, J.
    Posen, A.
    Van Hootegem, A.
    Van Moerkercke, W.
    Vermeire, S.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S22 - S23
  • [8] Integrin Calculus: The Predictive Power of Vedolizumab Concentrations in IBD Therapy
    Konstantinos Papamichael
    Adam S. Cheifetz
    Digestive Diseases and Sciences, 2019, 64 : 1397 - 1398
  • [9] Integrin Calculus: The Predictive Power of Vedolizumab Concentrations in IBD Therapy
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (06) : 1397 - 1398
  • [10] Confocal laser endomicroscopy predicts response in patients with acute inflammatory bowel disease undergoing anti-integrin therapy with Vedolizumab.
    Ellrichmann, Mark
    Bethge, Johannes
    Aust, Golo
    Arlt, Alexander
    Brandt, Berenice
    Zeissig, Sebastian
    Nikolaus, Susanna
    Aden, Konrad
    Schreiber, Stefan
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB154 - AB154
12345